doi: 10.1007/s10549-008-0172-5.
Epub 2008 Sep 13.
Anthracyclines and trastuzumab; getting to the heart of the matter: when getting to the heart is the matter
Affiliations
- PMID: 18791822
- DOI: 10.1007/s10549-008-0172-5
Item in Clipboard
Anthracyclines and trastuzumab; getting to the heart of the matter: when getting to the heart is the matter
Breast Cancer Res Treat.
2011 Jun.
No abstract available
Similar articles
-
Trastuzumab before breast surgery? Large trial says yes but does not quell debate.J Natl Cancer Inst. 2009 Apr 1;101(7):448-9. doi: 10.1093/jnci/djp072. Epub 2009 Mar 24. J Natl Cancer Inst. 2009. PMID: 19318626 No abstract available.
-
Reversibility of trastuzumab cardiotoxicity: is the concept alive and well?J Clin Oncol. 2007 Dec 1;25(34):5532-3; author reply 5533-4. doi: 10.1200/JCO.2007.14.0657. J Clin Oncol. 2007. PMID: 18048835 No abstract available.
-
Adjuvant therapy for HER2 positive breast cancer: are anthracyclines still necessary?Clin Adv Hematol Oncol. 2008 Sep;6(9):666-72. Clin Adv Hematol Oncol. 2008. PMID: 18827789
-
Therapy Insight: anthracyclines and trastuzumab--the optimal management of cardiotoxic side effects.Nat Clin Pract Oncol. 2008 Jun;5(6):324-35. doi: 10.1038/ncponc1090. Epub 2008 Mar 25. Nat Clin Pract Oncol. 2008. PMID: 18364726 Review.
-
Clinical cardiac tolerability of trastuzumab.J Clin Oncol. 2004 Jan 15;22(2):322-9. doi: 10.1200/JCO.2004.01.120. J Clin Oncol. 2004. PMID: 14722042 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
